| Literature DB >> 29304904 |
Mónica Macías1, Estibaliz Alegre2, Angel Díaz-Lagares3, Ana Patiño2, Jose L Pérez-Gracia2, Miguel Sanmamed4, Rafael López-López3, Nerea Varo2, Alvaro González5.
Abstract
Liquid biopsy refers to the molecular analysis in biological fluids of nucleic acids, subcellular structures, especially exosomes, and, in the context of cancer, circulating tumor cells. In the last 10 years, there has been an intensive research in liquid biopsy to achieve a less invasive and more precise personalized medicine. Molecular assessment of these circulating biomarkers can complement or even surrogate tissue biopsy. Because of this research, liquid biopsy has been introduced in clinical practice, especially in oncology, prenatal screening, and transplantation. Here we review the biology, methodological approaches, and clinical applications of the main biomarkers involved in liquid biopsy.Entities:
Keywords: Cancer; Cell-free DNA; Circulating tumor cells; Exosomes; Liquid biopsy; Pregnancy; Transplantation; microRNA
Mesh:
Substances:
Year: 2017 PMID: 29304904 DOI: 10.1016/bs.acc.2017.10.003
Source DB: PubMed Journal: Adv Clin Chem ISSN: 0065-2423 Impact factor: 5.394